Accenture PLC

Market Movers (8-K)

NYSE
Accenture Capital Inc. has successfully closed the sale of $4.997 billion in aggregate principal amount of senior notes and floating rate notes, guaranteed by Accenture plc.
Capital raise
NYSE
Accenture announced solid third-quarter fiscal 2026 financial results, showcasing revenue growth, strong profitability, EPS increase, and robust free cash flow, leading to an updated full-year revenue growth forecast.
NYSE
Accenture plc has entered into new credit agreements totaling $8.1 billion, replacing its previous $5.5 billion facility and increasing its commercial paper issuance capacity.
NYSE
Accenture reported strong second-quarter fiscal 2026 results with record new bookings and revenues at the top of its guided range, leading to an increased full-year free cash flow and earnings per share outlook.
Better than expected
NYSE
Accenture plc shareholders approved an amendment to its 2010 Share Incentive Plan, authorizing an additional 7 million shares and extending its term, alongside the election of ten directors and other key proposals.
NYSE
Accenture reported strong first-quarter fiscal 2026 results with $20.9 billion in new bookings and 5% local currency revenue growth, reaffirming its full-year outlook.
Better than expected

Quarterly Earnings (10-Q)

NYSE
Accenture plc announced its third quarter fiscal year 2026 financial results, reporting a 6% increase in revenue to $18.7 billion and a 9% rise in diluted earnings per share to $3.80.
NYSE
Accenture plc announced an 8% revenue increase to $18.0 billion in Q2 FY26, alongside robust operating cash flow and continued strategic investments in AI.
Better than expected
Capital raise
NYSE
Accenture reports 6% revenue growth and strong new bookings in Q1 fiscal 2026, while diluted EPS saw a slight GAAP decrease offset by adjusted growth due to business optimization costs.
Capital raise
Worse than expected
NYSE
Accenture plc announced robust financial performance for the third quarter and first nine months of fiscal year 2025, with significant increases in revenues, operating income, and diluted earnings per share, despite a decline in new bookings and ongoing economic uncertainties.
Delay expected
Better than expected
Capital raise
NYSE
Accenture's Q2 2025 results show revenue growth driven by strong performance in the Americas and EMEA, with new bookings remaining robust.
NYSE
Accenture's first quarter of fiscal year 2025 shows a 9% revenue increase in U.S. dollars and 8% in local currency, alongside a rise in diluted earnings per share to $3.59.
Better than expected

Annual Reports (10-K)

NYSE
Accenture plc announced robust fiscal year 2025 results, with revenues up 7% to $69.7 billion, driven by strategic investments in AI and digital transformation, despite increased business optimization costs.
Delay expected
Capital raise
NYSE
Accenture's fiscal year 2024 annual report highlights strategic investments in acquisitions, R&D, and talent development, alongside a focus on delivering 360 value to clients and stakeholders.

Insider Trading (Form 4)

NYSE
Melissa A Burgum, Chief Accounting Officer of Accenture plc, received 778 shares of common stock on August 1, 2026.
NYSE
Joel Unruch, General Counsel/Corp Secretary of Accenture plc, sold 10,498 shares of common stock on July 30, 2026.
NYSE
Joel Unruch, General Counsel and Corporate Secretary of Accenture plc, acquired 202 Class A ordinary shares through the company's Voluntary Equity Investment Program.
NYSE
Accenture plc reports a purchase of Class A ordinary shares by Chair and CEO Julie Spellman Sweet through the company's Voluntary Equity Investment Program.
NYSE
Accenture's Chief Leadership & HR Officer, Katherine Lee Clifford, acquired 128 Class A ordinary shares through an employee investment program.
NYSE
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc, acquired 157 Class A ordinary shares through the company's Voluntary Equity Investment Program.

Proxy Statements (Def-14A)

NYSE
Accenture plc announces its 2026 Annual General Meeting, detailing proposals for board appointments, executive compensation, and share plan approvals.
NYSE
Accenture's 2026 proxy statement highlights strong fiscal year 2025 financial performance, strategic advancements in AI, and proposed governance matters for shareholder vote.
Capital raise
Better than expected
NYSE
Accenture plc has scheduled its 2025 Annual General Meeting for February 6, 2025, and is providing shareholders with details on how to vote on key proposals.
NYSE
Accenture's upcoming annual general meeting will include the election of directors, approval of executive compensation, and several Irish law proposals.
Better than expected

Institutional Holdings (13F)

NYSE
Accenture PLC reports its holdings for the quarter ended September 30, 2024, with no securities listed in the information table.
NYSE
Accenture PLC reports its holdings for the quarter ended June 30, 2024, with no securities listed in the information table.
NYSE
Accenture PLC's latest 13F filing discloses its holdings as of March 31, 2024, revealing minimal reportable securities.
Worse than expected

Schedule 13G - Passive Investments

NYSE
Vanguard Capital Management has reported a beneficial ownership of 7.51% in Accenture PLC's common stock as of March 31, 2026.
NYSE
The Vanguard Group has amended its Schedule 13G filing for Accenture PLC, reporting 0% beneficial ownership following an internal realignment.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing an 8.3% beneficial ownership stake in Accenture PLC's Class A Stock as of December 31, 2025.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting a 10.19% beneficial ownership stake in Accenture PLC as of March 31, 2025.